17 SEPTEMBER 2020, THURSDAY

16:45-17:00

AHOS 2020 - Opening Remarks

Summary of the six previous AHOS

Guray Saydam, TR - Evangelos Terpos, GR

17:00-18.00

SESSION 1: MYELODYSPLASTIC SYNDROMES

Osman Ilhan, TR - Despina Mparmparoussi, GR

Chairs:

Lecture 1

CHIP, ICUS, CCUS: basics and beyond

Mustafa Çetiner, TR

Case Presentation

45-year of age patient with hypoplastic MDS

Itır Şirinoğlu Demiriz, TR

Chair:

Nora-Athina Vyniou, GR

Speaker:

Eleftheria Hatzimichael, GR

18:00-18:30

Satellite Lecture (sponsored by Takeda):Τhe role of NEDD8 inhibition in the management of HR-MDS and AML

Lecture 2

MDS and cardiovascular disease

Konstantinos Liapis, GR

Speaker:

18:30-19:00

Satellite Lecture (sponsored by Amgen):Reviewing Contemporary Evidence in ITP: Putting New Recommendations into Practice

Chair:

Speaker:

Vassiliki Pappa, GR

Athanasios Galanopoulos, GR

Chair:

Nora-Athina Vyniou, GR

Speaker:

Ioannis Kotsianidis, GR

19:00-19:30

Satellite Lecture (sponsored by BMS): Novel Approaches for the Management of Anemia in patients with Myelodysplastic Syndromes

Chair:

Vassiliki Pappa, GR

Speaker:

Maria Gamaletsou, GR

19:30-20:00

Satellite Lecture (sponsored by PFIZER): Fighting invasive mould fungal infections in patients with hematological malignancies

18 SEPTEMBER 2020, FRIDAY

17:00-18.00

SESSION 3: Myeloproliferative Neoplasms

Chairs:

Zahit Bolaman, TR – Flora Kontopidou, GR

Lecture 1:

Therapeutic algorithm for the treatment of myelofibrosis

Stavroula Giannouli, GR

Lecture 2:

Novel therapies for CML

Eren Arslan Davulcu, TR

18:00-18.30

Satellite Lecture (sponsored by NOVARTIS): Advanced Systemic Mastocytosis-Diagnostic Challenges and Treatment Management

Chair:

Speaker:

Georgios Vassilopoulos, GR

EvangelosTerpos, GR

18:30-19:00

Satellite Lecture (Sponsored by Pfizer): Management of comorbidities in patients with CML treated with 2GTKI

Chair:

Speaker:

Güray Saydam, TR

İbrahim Haznedaroglu, TR

19:00-19:30

Satellite Lecture (sponsored by Genesis): Optimizing treatment for patients with CP-CML. New recommendations and therapy goals

Chair:

Speaker:

Argiris Symeonidis, GR

Evgenia Verrou, GR

19:30-20:00

Meet the Expert Session 1. Bcl-2 inhibition in CLL: from where to where

Chairs:

Speaker:

Fahri Şahin, TR; Mahmut Töbü, TR

Niki Stavroyianni, GR

Argiris Symeonidis, GR

Speaker:

Ioannis Kotsianidis, GR

Chair:

Atilla Ozkan, TR

Treatment of a 21-year oldpatient with relapsed ALL after two

prior lines of therapy

Speaker:

Case presentation:

Elif Birtaş Ateşoğlu, TR

In favor of low intensity

Intensive versus low intensity treatment for AML

Debate:

Chairs:

Maria Pagoni, GR - Mehmet Sönmez, TR

12:00-13:00

SESSION 2: Acute Leukemias

13:00-13:30

Satellite Lecture (Sponsored by Abbvie): Leading the change in AML Treatment Algorithm

In favor of intensive treatment

Ioannis Tsonis, GR

13:30-14:00

Satellite Lecture (Sponsored by BMS): Novel treatment approaches for thalassemia patients

Speaker:

Chair:

Ersi Voskaridou, GR

Alexandra Kourakli, GR

14:00-17:00

Break   (15.30-16.30 Online meetings with sponsors at Exhibition Area)*

*Online zoom meetings with sponsors will be organized only for Turkish participants on Friday and Saturday between 15.30-16.30

19 SEPTEMBER 2020, SATURDAY

11:00-12:00

Common Symposium of AHOS with BMSG

Chair:

Debate:

Lecture:

Hayri Ozsan, TR

Should we Treat High-Risk Smoldering Myeloma

Novel Immunotherapies for Myeloma

Yes:

No:

12.00-12:30

Myeloma MoAb: Daratumumab in Relapsed/Refractory Multiple Myeloma

Chair

Mehmet Yılmaz, TR

Speaker

Nil Guler, TR

Efstathios Kastritis, GR

Gökmen Ömür Sevindik, TR

Speaker:

Meral Beksac, TR

12:30-13:00

Satellite Lecture (sponsored by SANOFI GENZYME): Isatuximab, Pomalidomide, Dexamethasone combination in 3L RRMM: Addressing a therapeutic gap

Chair

Speaker

13:00-13:30

Satellite Lecture (sponsored by Amgen): How to Maximize the benefit of New Developments in Multiple Myeloma: from Clinical Trials to Real-World Evidence

Chair

Evangelos Terpos, GR

Speaker

Emanouel Spanoudakis, GR

17:00-18:00

SESSION 4: LYMPHOMA

13:30-14:00

Satellite Lecture (sponsored by Takeda): Μaintenance therapy for Multiple Myeloma: treatment landscape, unmet needs and future perspectives

Marie-Christine Kyrtsonis, GR

Eirini Katodritou, GR

Chair

Speaker

14:00-17:00

Break   (15.30-16.30 Online meetings with sponsors at Exhibition Area)*

Anastasia Pouli, GR

Evangelos Terpos, GR

Chairs:

Burhan Ferhanoğlu, TR – Nikolaos Giannakoulas, GR

Debate:

BTK inhibitors must be used earlier in mantle-cell lymphoma therapy

Yes: Özgür Mehtap, TR

No:  Sotirios Papageorgiou, GR

Case presentation:

Succesful use of BTK inhibitor in a patient with relapsed/refractory lymphoma 

Speaker:

Fatma Keklik Karadağ, TR

18:00-18.30

Satellite Lecture (sponsored by Roche): PolatuzumabVedotin: Moving towards a new standard in R/R DLBCL disease management

Chair:

Speaker:

Panayiotis Panayiotidis, GR

Maria Angelopoulou, GR

18:30-19:00

Satellite Lecture (Sponsored by Amgen): Carfilzomib in Relapsed/Refractory Multiple Myeloma

Chair:

Speaker:

Tülin Tuğlular, TR,

Mehmet Ali Özcan, TR

19:00-19:30

Invited Speaker by the Co-Chairs

Chairs:

EvangelosTerpos, GR - Guray Saydam, TR

Presentation Title:

Molecular improvements in hematological malignancies

Speaker:

Yusuf Baran (Rector of IYTE, Izmir, TR)

19:30-20:00

Satellite Lecture (Sponsored by Abdi İbrahim)

İrfan Yavaşoğlu, TR - Gülsüm Özet, TR

Chairs:

Lecture 1

Iron chelation; what is happening.

Volkan Karakuş

Lecture 2

Antifungal Treatment in 2020

Orhan Kemal Yücel

*Online zoom meetings with sponsors will be organized only for Turkish participants on Friday and Saturday between 15.30-16.30

20 SEPTEMBER 2020, SUNDAY

11:00-12:00

SESSION 5: CAR-T therapy for hematological malignancies

Ali Ünal, TR – Ioannis Baltadakis, GR

Chairs:

Lecture 1

CAR-T therapy for ALL

Ali Ünal, TR

Lecture 2

CAR-T therapy for lymphomas

Panagiotis Tsirigotis, GR

12:00-13:30

SESSION 6: COVID-19 and Hematology

Birol Güvenç, TR; Ioanna Sakellari, GR

Chairs:

Lecture 1

Management of Lymphoma patients during COVID-19 pandemic

Mehmet Ali Uçar, TR

Lecture 2

Management of Leukemia patients during COVID-19 pandemic

Damianos Sotiropoulos, GR

Lecture 3

Thrombotic Complications of COVID-19

Asu Fergun Yilmaz, TR

13:30-13:45

Closing Remarks